Current Status of Dyslipidemia Treatment for Stroke Prevention

被引：19

作者：

Aradine, Elizabeth ^{[1
,2
]}

Hou, Yan ^{[1
,2
]}

Cronin, Carolyn A. ^{[1
,2
]}

Chaturvedi, Seemant ^{[1
,2
]}

机构：

[1] Univ Maryland, Sch Med, Stroke Div, 110 S Paca St, Baltimore, MD 21201 USA

[2] Univ Maryland, Sch Med, Dept Neurol, 110 S Paca St, Baltimore, MD 21201 USA

来源：

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2020年 / 20卷 / 08期

关键词：

Cholesterol; Stroke; Statins; Triglycerides; Low-density lipoprotein; HIGH-DOSE ATORVASTATIN; THERAPY; PRAVASTATIN; ATHEROSCLEROSIS; CHOLESTEROL; PROGRESSION; REDUCTION; EZETIMIBE; EFFICACY; DISEASE;

D O I：

10.1007/s11910-020-01052-4

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Purpose of Review Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. Recent Findings However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin-kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.

引用

页数：8

共 33 条

[1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[2] A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke [J].

Amarenco, P. ;

Kim, J. S. ;

Labreuche, J. ;

Charles, H. ;

Abtan, J. ;

Bejot, Y. ;

Cabrejo, L. ;

Cha, J-K ;

Ducrocq, G. ;

Giroud, M. ;

Guidoux, C. ;

Hobeanu, C. ;

Kim, Y. J. ;

Lapergue, B. ;

Lavallee, P. C. ;

Lee, B-C ;

Lee, K-B ;

Leys, D. ;

Mahagne, M-H ;

Meseguer, E. ;

Nighoghossian, N. ;

Pico, F. ;

Samson, Y. ;

Sibon, I ;

Steg, P. G. ;

Sung, S-M ;

Touboul, P. J. ;

Touze, E. ;

Varenne, O. ;

Vicaut, E. ;

Yelles, N. ;

Bruckert, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :9-19

[3]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

[4]

Amarin Pharmaceuticals Ireland Ltd, VASCEPA IC ETH CAPS

[5]

Amgen Inc, REPATHA EV INJ SUBC

[6]

[Anonymous], 2001, MERCK SCHER PLOUGH P

[7]

[Anonymous], PRALUENT AL INJ SUBC

[8] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].

Bhatt, Deepak L. ;

Steg, P. Gabriel ;

Miller, Michael ;

Brinton, Eliot A. ;

Jacobson, Terry A. ;

Ketchum, Steven B. ;

Doyle, Ralph T., Jr. ;

Juliano, Rebecca A. ;

Jiao, Lixia ;

Granowitz, Craig ;

Tardif, Jean-Claude ;

Ballantyne, Christie M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22

[9] Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [J].

Bohula, Erin A. ;

Wiviott, Stephen D. ;

Giugliano, Robert P. ;

Blazing, Michael A. ;

Park, Jeong-Gun ;

Murphy, Sabina A. ;

White, Jennifer A. ;

Mach, Francois ;

Van de Werf, Frans ;

Dalby, Anthony J. ;

White, Harvey D. ;

Tershakovec, Andrew M. ;

Cannon, Christopher P. ;

Braunwald, Eugene .

CIRCULATION, 2017, 136 (25) :2440-+

[10] The effects of statin therapy on carotid plaque composition and volume: A systematic review and meta-analysis [J].

Brinjikji, Waleed ;

Lehman, Vance T. ;

Kallmes, David F. ;

Rabinstein, Alejandro A. ;

Lanzino, Giuseppe ;

Murad, Mohammad H. ;

Mulvagh, Sharon ;

Klaas, James ;

Graff-Radford, Jonathan ;

DeMarco, Kevin J. ;

Huston, John, III .

JOURNAL OF NEURORADIOLOGY, 2017, 44 (04) :234-240

← 1 2 3 4 →